Pharmacological treatment of respiratory symptoms

Currow, DC; Abernethy, AP

Pharmacological treatment of respiratory symptoms

Currow, DC

Abernethy, AP

Permalink

Publication Type:: Chapter
Citation:: Supportive Care in Respiratory Disease, 2012
Issue Date:: 2012-05-24

Closed Access

	Filename	Description	Size
	20171130110830644.pdf	Published version	4.81 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Currow, DC https://orcid.org/0000-0003-1988-1250	en_US
dc.contributor.author	Abernethy, AP	en_US
dc.date.issued	2012-05-24	en_US
dc.identifier.citation	Supportive Care in Respiratory Disease, 2012	en_US
dc.identifier.isbn	9780199591763	en_US
dc.identifier.uri	http://hdl.handle.net/10453/120984
dc.description.abstract	© Oxford University Press, 2012. All rights reserved. This chapter discusses the pharmacological management of breathlessness. Opioids have demonstrated benefit without documented respiratory toxicity. Several psychotropic agents and nebulized furosemide have sufficient promise to warrant rigorous prospective studies. Ultimately, reducing the frightening sensation of breathlessness is something that can be achieved predictably with medications currently available.	en_US
dc.relation.ispartof	Supportive Care in Respiratory Disease	en_US
dc.relation.isbasedon	10.1093/acprof:oso/9780199591763.003.0007	en_US
dc.title	Pharmacological treatment of respiratory symptoms	en_US
dc.type	Chapter
utslib.for	1110 Nursing	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
utslib.copyright.status	closed_access
pubs.publication-status	Published	en_US

Abstract:

© Oxford University Press, 2012. All rights reserved. This chapter discusses the pharmacological management of breathlessness. Opioids have demonstrated benefit without documented respiratory toxicity. Several psychotropic agents and nebulized furosemide have sufficient promise to warrant rigorous prospective studies. Ultimately, reducing the frightening sensation of breathlessness is something that can be achieved predictably with medications currently available.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/120984